May 17, 2018 / 11:13 AM / 4 days ago

BRIEF-Vbl Therapeutics Announces Q1 Loss Per Share $0.24

May 17 (Reuters) - Vascular Biogenics Ltd:

* VBL THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.24

* SAYS CASH, CASH EQUIVALENTS AND SHORT-TERM BANK DEPOSITS AT MARCH 31, 2018, WERE $49.9 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below